Back to search
FDAFDA · Food and drugs·Recall number Z-2703-2026

Atellica CH Enzymatic Hemoglobin A1c (A1c_E). Material Number: 11097536.

Published July 15, 2026 · Recall initiated: June 8, 2026

Summary

FDA records medical device Class II recall Z-2703-2026, published July 15, 2026 and initiated June 8, 2026. Recalling firm: Siemens Healthcare Diagnostics, Inc.; Status: Ongoing; Reported quantity: 24,077 units; Lot: Material Number: 11097536. UDI-DI: 00630414220505. All Lot Numbers. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The potential for intermittent well-to-well bias on the A1c_E assay on the Atellica CH and Atellica CI analyzer which could cause falsely depressed or falsely elevated HbA1c patient results.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Siemens Healthcare Diagnostics, Inc.
Distributor
Worldwide distribution - US Nationwide and the countries of Argentina, Australia, Austria, Bahamas, Bangladesh, Bolivia, Brazil, Bulgaria, Burkina®Faso, Canada, Chile, China, Colombia, Croatia, Cura®ao,¿St®Eus, Czech®Republic, Democratic Republic Congo, Denmark, Ecuador, Egypt, El Salvador, Estonia, Finland, France, Georgia, Germany, Greece, Hong Kong, India, Indonesia, Israel, Italy, Japan, Jordan, Kenya, Kuwait, Latvia, Lebanon, Lithuania, Macedonia, Malaysia, Mexico, Netherlands, New Zealand, Norway, Oman, Pakistan, Paraguay, Poland, Portugal, Qatar, Republic of Korea, Romania, Saudi®Arabia, Serbia, Singapore, Slovakia, Slovenia, South Africa, Spain, Switzerland, Thailand, Turkey, Turkmenistan, U.A.E., Uganda, United®Kingdom, Uruguay, Vatican City, Vietnam.
Lot
Material Number: 11097536. UDI-DI: 00630414220505. All Lot Numbers.
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Atellica CH Enzymatic Hemoglobin A1c (A1c_E). Material Number: 11097536. recalled?

Yes. FDA published recall Z-2703-2026 on July 15, 2026. Reported hazard: The potential for intermittent well-to-well bias on the A1c_E assay on the Atellica CH and Atellica CI analyzer which could cause falsely depressed or falsely elevated HbA1c patient results.

What should I do if I have this product?

Voluntary: Firm initiated · Letter